Skip to product information
1 of 2

Recombinant Human RSPO1 (C-6His)

Recombinant Human RSPO1 (C-6His)

Recombinant Human R-spondin-1 is produced by our Mammalian expression system and the target gene encoding Ser21-Ala263 is expressed with a 6His tag at the C-terminus.

Catalog No: EPT157
Regular price $589.00 USD
Regular price Sale price $589.00 USD
Sale Sold out
Packaging
Download PDF

Product Details

Accession Q2MKA7
Molecular Weight 27.8 KDa
Apparent Molecular Weight 40 KDa, reducing conditions
Purity Greater than 95% as determined by reducing SDS-PAGE.
Endotoxin Less than 0.01 EU/µg as determined by LAL test.
Expression Host Mammalian
Reconstitution Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. 
Shipping Condition The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed in the Storage field.
Storage Condition and Shelf Life Lyophilized protein should be stored at < -20C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20C for 3 months.
Background RSPO1 is a secreted protein,containing 2 FU(furin-like) repeats and 1 TSP type-1 domain and belonging to the R-spondin family. RSPO1 is required for the early development of gonads, regardless of sex. It has been found in mice only eleven days after fertilization. To induce cell proliferation, it acts synergistically with WNT4. They help stabilize β catenin, which activates downstream targets. RSPO1 is necessary in female sex development. It augments the WNT/β catenin pathway to oppose male sex development. In critical gonadal stages, between six and nine weeks after fertilization, the ovaries upregulate it while the testes downregulate it. RSPO1 can potentially aid in the treatment of mucositis, which is characterized by inflammation of the oral cavity. This unfortunate condition often accompanies chemotherapy and radiation in cancer patients with head and neck tumors.
Analyte RSPO1
Regulatory Status For Research Use Only
View full details

Inquire about this product